1.34

1.47% -0.02

After Hours: 1.35 0.01 +0.75%

Enveric Biosciences Inc (ENVB)

Overview News Price History Financials Discussions Forecast Stock Split Dividend History

Enveric Biosciences Inc stock is traded at $1.34, with a volume of 172.73K. It is down -1.47% in the last 24 hours and up +3.08% over the past month. Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

Previous Close:

$1.36

Open:

$1.44

24h Volume:

172.73K

Relative Volume:

0.05

Market Cap:

$5.40M

Revenue:

Net Income/Loss:

$-8.22M

P/E Ratio:

-0.049

EPS:

-27.3467

Net Cash Flow:

$-8.01M

1W Performance:

-0.74%

1M Performance:

+3.08%

6M Performance:

-65.82%

1Y Performance:

-91.28%

1-Day Range:

$1.30

$1.44

1-Week Range:

$1.28

$1.4932

52-Week Range:

$1.26

$17.64

Enveric Biosciences Inc Stock (ENVB) Company Profile

Name

Enveric Biosciences Inc

Sector

Healthcare (1092)

Industry

Biotechnology (603)

Phone

(617) 444-8400

Address

245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

ENVB's Discussions on Twitter

Compare ENVB vs VRTX, REGN, ARGX, RVMD, ALNY

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ENVB Enveric Biosciences Inc	1.34	5.48M	0	-8.22M	-8.01M	-27.35
VRTX Vertex Pharmaceuticals Inc	485.65	123.36B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	676.69	71.18B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	860.55	53.68B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	186.16	38.09B	742.00K	-1.37B	-1.07B	-7.0731
ALNY Alnylam Pharmaceuticals Inc	267.47	37.80B	4.29B	577.22M	641.34M	4.2086

Enveric Biosciences Inc Stock (ENVB) Latest News

Jul 16, 2026

FDA Fast-Tracks Psychedelic Research After Trump’s Executive Order — CMPS, HELP Stocks Gain - Stocktwits

Jul 16, 2026

Enveric Biosciences (ENVB) Rebounds Slightly, Testing Key Resistance Near $1.50Earnings Miss Risk - dars.gov.et

Jul 09, 2026

Jul 07, 2026

Price to earnings forward of Enveric Biosciences, Inc. – NASDAQ:ENVB - TradingView

Jul 07, 2026

Jul 03, 2026

ENVB Q4 2024 Earnings: Significant EPS Miss Highlights Ongoing R&D Investment Amid Pre-Revenue StageEarnings Quality Score - dars.gov.et

Jul 03, 2026

Jun 29, 2026

Enveric Biosciences to Participate in B. Riley's Mind, Muscle & Vision Summit - GuruFocus

Jun 29, 2026

Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit - Business Wire

Jun 29, 2026

Enveric CEO to discuss EB-003 at Boston neuropsychiatry summit - Stock Titan

Jun 29, 2026

Jun 27, 2026

Enveric Biosciences Announces Withdrawal Of Petition Against Its Patent — ENVB Stock Rises - Stocktwits

Jun 27, 2026

ENVBEnveric Biosciences Inc Earnings - Finviz

Jun 27, 2026

Jun 26, 2026

Enveric Biosciences Company Profile & Introduction - Moomoo

Jun 26, 2026

Enveric Biosciences, Inc. Actuals & Estimates (NASDAQ:ENVB) - TradingView

Jun 26, 2026

Jun 19, 2026